Phlow Corp.
PrivateLast Round
Series C
Jul 22, 2025
Total Funding Raised
$447M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Phlow Corp. is a pharmaceutical company that provides contract development and manufacturing of active pharmaceutical ingredients and essential medicines.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Smart Manufacturing, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phlow Corp. Comps
Public and private peers based on sector, stage, and business model.
Phlow Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 22, 2025 | ||||
| Series B | Apr 5, 2023 | ||||
| Series A | Feb 16, 2021 | ||||
| Grant | May 19, 2020 |
Phlow Corp. Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Dawn Von Rohr appointed as the new COO.
- Mar 18, 2026
Partnering with Fresenius Kabi for API production and final formulation.
Phlow Corp. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
